Stock analysis searches answered, part 7 of 43

Oneim acquisition a (oim) news october 2026

This section ties “Oneim acquisition a (oim) news october 2026” to OneIM Acquisition Corp. (ticker OIM, OIMAU, OIMAW), SEC Central Index Key 2088325, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-13, and this view starts from filings dated on or before 2026-02-27. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-30 by OneIM Acquisition Corp. (CIK 2088325) (passage 2, continuing from the earlier excerpt) — source document:

On September 11, 2025, the Sponsor purchased 7,187,500 shares of Class B ordinary shares, par value $0.0001 per share, of the Company (the “Founder Shares”) for $25,000, or approximately $0.003 per share. On January 9, 2026, the Sponsor transferred 25,000 Founder Shares to each of the independent directors at their original purchase price. On January 15, 2026 (the “IPO Closing Date”), we consummated our IPO of 28,750,000 units (the “Units”) of the Company. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share, and one-sixth of one warrant of the Company (“Warrant”), each whole Warrant entitling the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share.

For the latest news, the fastest official source is the filing feed: OneIM Acquisition Corp. (CIK 2088325) filed 3 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-03-05, and its overall latest filing is a SCHEDULE 13G/A dated 2026-08-13. Companies must file an 8-K within four business days of most material events.

Other filings. Across its 26 recent EDGAR filings, OneIM Acquisition Corp. most often filed SCHEDULE 13G (5), 3 (5), 10-Q (3), 8-K (3). A selection from 2026-02-27 to 2026-05-11:

The full record for CIK 2088325 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2025-10-09. One example from this record is the SCHEDULE 13G filed 2026-05-13 (document). Insider trades for OneIM Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Quantum leap acquisition a (qlep) news october 2026

This section ties “Quantum leap acquisition a (qlep) news october 2026” to Quantum Leap Acquisition Corp (ticker QLEP, QLEP-WT), SEC Central Index Key 2102155, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-14. Nothing here is a recommendation to trade the security.

Financial trend for Quantum Leap Acquisition Corp from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from -$48,012 (2026-03-31) to $669,181 (2026-06-30), a change of +1493.8%; total assets went from $398,860 (2026-03-31) to $234.98 million (2026-06-30), a change of +58812.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2102155, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Quantum Leap Acquisition Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Quantum Leap Acquisition Corp (CIK 2102155) filed 6 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-07-08, and its overall latest filing is a 10-Q dated 2026-08-14. Companies must file an 8-K within four business days of most material events.

Deal and listing documents for Quantum Leap Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 6 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-05-04.

Current reports. Of the 6 8-K or 6-K reports in Quantum Leap Acquisition Corp’s recent EDGAR index, the 4 listed here run from 2026-05-18 to 2026-07-08, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 36 recent EDGAR filings, Quantum Leap Acquisition Corp most often filed 8-K (6), 3 (6), SCHEDULE 13G (5), CORRESP (3). A selection from 2026-08-11 to 2026-08-14:

The full record for CIK 2102155 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-12-23. Insider trades for Quantum Leap Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Quantumsphere acquisition (qums) news october 2026

This section ties “Quantumsphere acquisition (qums) news october 2026” to Quantumsphere Acquisition Corp (ticker QUMS, QUMSR, QUMSU), SEC Central Index Key 2070900, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 425 dated 2026-10-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-06-15 by Quantumsphere Acquisition Corp (CIK 2070900) — source document:

We are a Cayman Islands exempted company with limited liability incorporated on July 23, 2024. We are formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses (the “Business Combination”). Initial Public Offering and Private Placement In March 2025, the Company issued 2,415,000 shares of ordinary shares, $0.0001 per share to the Sponsor, the founder shares, for an aggregated consideration of $25,000, or approximately $0.0104 per share. On August 5, 2025, the Company and the Sponsor entered into the First Amendment to the Subscription Agreement, pursuant to which the purchased amount of founder shares was adjusted to 2,898,000, of which 378,000 are subject to forfeiture.

Financial trend for Quantumsphere Acquisition Corp from annual reports, periods 2025-03-31 to 2026-03-31: net income (loss) was tagged only for 2026-03-31 at $978,206; total assets went from $248,982 (2025-03-31) to $85.20 million (2026-03-31), a change of +34119.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2070900, tags Assets, ProfitLoss; 2 periods shown, dashes mark figures Quantumsphere Acquisition Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Quantumsphere Acquisition Corp (CIK 2070900) filed 8 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-13, and its overall latest filing is a 425 dated 2026-10-13. Companies must file an 8-K within four business days of most material events.

Deal and listing documents for Quantumsphere Acquisition Corp — registration statements, prospectuses and merger proxies — are filed on EDGAR; 7 such filings (424B4, 425, S-1, S-1/A, S-1MEF) appear in its recent index, the newest dated 2026-10-13.

Current reports. Of the 8 8-K or 6-K reports in Quantumsphere Acquisition Corp’s recent EDGAR index, the 4 listed here run from 2026-01-23 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2070900 is on the EDGAR company page; the latest 10-K/A there is dated 2026-07-01 and the oldest filing in the recent index dates from 2025-05-30. Insider trades for Quantumsphere Acquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rga life insurance company of canada mobile apps

“Rga life insurance company of canada” is searched here together with “mobile apps”, so the question is which apps the business publishes, not its SEC record. App listings show the developer’s legal name; the authoritative places to check are Google Play’s developer search and Apple’s App Store, where an app published by Rga life insurance company of canada would show that exact name under “Developer” or “Seller”.

No SEC filer could be matched to “Rga life insurance company of canada mobile apps” with a single, clear Central Index Key: the phrase “Rga life insurance company of canada” appears in 1 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “rga” (search terms considered: rga, life, insurance, canada).

A broader EDGAR full-text search for the shorter phrase “Rga life insurance” finds 1 filing documents; among the top 1, the filers mentioning it most are MANULIFE FINANCIAL CORP (MFC, MNLCF, MNQFF, MNUFF) (CIK 0001086888) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Canada. Companies there file with the Canadian Securities Administrators’ SEDAR+ system rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “rga” is therefore the Canada regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 1 most relevant full-text hits returned for “Rga life insurance company of canada”, filings range from 2024-11-06 to 2024-11-06. The filers whose documents mention it most often are MANULIFE FINANCIAL CORP (MFC, MNLCF, MNQFF, MNUFF) (CIK 0001086888) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

Word by word, the number of EDGAR registrant names containing each term of this search is: “rga” 8, “life” 480, “insurance” 481, “canada” 475. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Updated Oct 25, 2026 ET

Rice acquisition 3 a (krsp) news october 2026

This section ties “Rice acquisition 3 a (krsp) news october 2026” to Rice Acquisition Corp 3 (ticker KRSP, KRSP-UN, KRSP-WT), SEC Central Index Key 2074872, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-19 by Rice Acquisition Corp 3 (CIK 2074872) — source document:

We are a blank check company incorporated on June 6, 2025, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this Report as our “initial business combination.” We are an early stage and emerging growth company and, as such, we are subject to all of the risks associated with early stage and emerging growth companies. On June 20, 2025, our sponsor received 9,487,500 Class B units of Opco for no consideration and purchased 9,487,500 of the company’s Class B ordinary shares, par value $0.0001, 2,500 of the company’s Class A ordinary shares, 100 Class A units of Opco and 100 corresponding class B ordinary shares of the company for aggregate consideration of $26,000.

Financial trend for Rice Acquisition Corp 3 from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from -$64,218 (2025-09-30) to $2.72 million (2026-06-30), a change of +4342.0%; total assets went from $13.45 million (2025-09-30) to $357.15 million (2026-06-30), a change of +2555.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2074872, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Rice Acquisition Corp 3 did not tag for that period.

For the latest news, the fastest official source is the filing feed: Rice Acquisition Corp 3 (CIK 2074872) filed 3 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2025-11-18, and its overall latest filing is a SCHEDULE 13G/A dated 2026-08-14. Companies must file an 8-K within four business days of most material events.

Deal and listing documents for Rice Acquisition Corp 3 — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-10-02.

Current reports. Of the 3 8-K or 6-K reports in Rice Acquisition Corp 3’s recent EDGAR index, the 3 listed here run from 2025-10-06 to 2025-11-18, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2074872 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2025-07-29. Insider trades for Rice Acquisition Corp 3 appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Staar surgical

This section ties “Staar surgical” to STAAR SURGICAL CO (ticker STAA), SEC Central Index Key 718937, an EDGAR registrant classified as “Ophthalmic Goods” and organised in DE, formerly known as STAAR SURGICAL COMPANY. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K/A dated 2026-10-05. Nothing here is a recommendation to trade the security.

Financial trend for STAAR SURGICAL CO from annual reports, periods 2022-12-30 to 2026-01-02: revenue went from $239.44 million (2022-12-30) to $239.44 million (2026-01-02), a change of +0.0%; net income (loss) went from $39.66 million (2022-12-30) to -$80.45 million (2026-01-02), a change of -302.8%; total assets went from $418.82 million (2022-12-30) to $451.68 million (2026-01-02), a change of +7.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 718937, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures STAAR SURGICAL CO did not tag for that period.

STAAR SURGICAL CO has 1000 filings in its recent EDGAR index, including 13 annual reports and 39 quarterly reports; its newest filing is a 8-K/A from 2026-10-05.

Current reports. Of the 236 8-K or 6-K reports in STAAR SURGICAL CO’s recent EDGAR index, the 4 listed here run from 2026-06-22 to 2026-09-10, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1000 recent EDGAR filings, STAAR SURGICAL CO most often filed 4 (409), 8-K (236), DEFA14A (45), SC 13G/A (42). A selection from 2026-08-14 to 2026-10-05:

The full record for CIK 718937 is on the EDGAR company page; the latest 10-K there is dated 2026-03-03 and the oldest filing in the recent index dates from 2013-08-14. Insider trades for STAAR SURGICAL CO appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Uy scuti acquisition (uysc) news october 2026

This section ties “Uy scuti acquisition (uysc) news october 2026” to UY Scuti Acquisition Corp. (ticker UYSC, UYSCR, UYSCU), SEC Central Index Key 2036973, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 425 dated 2026-10-23, and this view starts from filings dated on or before 2026-08-06. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-07-14 by UY Scuti Acquisition Corp. (CIK 2036973) (passage 2, continuing from the earlier excerpt) — source document:

Our sponsor is UY Scuti Investments Limited, a British Virgin Islands company, which was recently formed to invest in our company. Although our sponsor is permitted to undertake any activities permitted under British Virgin Islands law and other applicable law, our sponsor’s business is focused on investing in our company. Although each of our officers and directors is a shareholder of our sponsor; only Qunxue Yin, the sole director of our sponsor, holds voting securities in our sponsor and has the power to vote or dispose of the securities. On August 2, 2024, our sponsor purchased an aggregate of 1,725,000 ordinary shares (“Founder Shares”) (up to 225,000 of which were subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ option to purchase additional units is exercised) for an aggregate purchase price of $25,000, or approximately $0.02 per share.

Financial trend for UY Scuti Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $151,992 (2025-09-30) to $164,865 (2026-06-30), a change of +8.5%; total assets went from $58.97 million (2025-09-30) to $35.65 million (2026-06-30), a change of -39.5%. Values are as filed and not adjusted for restatements, splits or currency.

For the latest news, the fastest official source is the filing feed: UY Scuti Acquisition Corp. (CIK 2036973) filed 17 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-23, and its overall latest filing is a 425 dated 2026-10-23. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 17 8-K or 6-K reports in UY Scuti Acquisition Corp.’s recent EDGAR index, the 4 listed here run from 2026-03-30 to 2026-07-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2036973 is on the EDGAR company page; the latest 10-K there is dated 2026-07-14 and the oldest filing in the recent index dates from 2024-09-30. One example from this record is the 425 filed 2026-09-24 (document). Insider trades for UY Scuti Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

X3 acquisition a (xcbe) news october 2026

This section ties “X3 acquisition a (xcbe) news october 2026” to X3 Acquisition Corp. Ltd. (ticker XCBE, XCBEU, XCBEW), SEC Central Index Key 2083493, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-25 by X3 Acquisition Corp. Ltd. (CIK 2083493) — source document:

We are a blank check company incorporated in the Cayman Islands as an exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. We have neither engaged in any operations nor generated any revenue to date. Based on our business activities, the Company is a “shell company” as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) because we have no operations and nominal assets consisting almost entirely of cash. On August 18, 2025, we issued to our sponsor an aggregate of 5,750,000 Class B ordinary shares (the “founder shares”) for an aggregate purchase price of $25,000, or approximately $0.004 per share.

Financial trend for X3 Acquisition Corp. Ltd. from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $913,196 (2026-03-31) to $1.84 million (2026-06-30), a change of +102.0%; total assets went from $227.87 million (2026-03-31) to $229.72 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2083493, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures X3 Acquisition Corp. Ltd. did not tag for that period.

For the latest news, the fastest official source is the filing feed: X3 Acquisition Corp. Ltd. (CIK 2083493) filed 4 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-03-10, and its overall latest filing is a 10-Q dated 2026-08-14. Companies must file an 8-K within four business days of most material events.

Deal and listing documents for X3 Acquisition Corp. Ltd. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-01-21.

Current reports. Of the 4 8-K or 6-K reports in X3 Acquisition Corp. Ltd.’s recent EDGAR index, the 4 listed here run from 2026-01-22 to 2026-03-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2083493 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2025-09-16. Insider trades for X3 Acquisition Corp. Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

(rocket lab corporation or lockheed martin corp. or l3harris technologies, inc. or redwire corporation) and (rklb or lmt or lhx or rdw) and (news or updates or financials or announcements) and (contracts or earnings or guidance or reports) and (2026 or recent)

A second Boolean phrasing for Rocket Lab, Lockheed Martin, L3Harris and Redwire, this time asking for news, contracts, earnings or guidance. What follows is each company’s own disclosure trail as EDGAR showed it on Oct 25, 2026.

LOCKHEED MARTIN CORP (LMT) — EDGAR lists the 8-K of 2025-12-18 covering 8.01 (other events); the 8-K of 2025-12-09 covering 1.01 (entry into a material definitive agreement), 9.01 (financial statements and exhibits). Year to 2022-12-31: annual sales of $65.98 billion, net result $5.73 billion (10-K, 2025-01-28).

Rocket Lab Corp (RKLB) — recent current reports: the 8-K of 2026-08-10 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-06-29 covering 1.01 (entry into a material definitive agreement), 7.01 (regulation fd disclosure), 9.01 (financial statements and exhibits). Year to 2023-12-31: revenue of $244.59 million, net income (loss) -$182.57 million (10-K, 2026-02-26).

L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX) — recent current reports: the 8-K of 2026-05-12 covering 5.07 (submission of matters to a vote of security holders), 9.01 (financial statements and exhibits); the 8-K of 2026-04-30 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits). Year to 2016-07-01: revenue of $5.99 billion, net income (loss) $324.00 million (10-K, 2018-08-27).

Redwire Corp (RDW) — recent current reports: the 8-K of 2026-06-09 covering 1.01 (entry into a material definitive agreement), 9.01 (financial statements and exhibits); the 8-K of 2026-05-20 covering 5.07 (submission of matters to a vote of security holders), 8.01 (other events). Year to 2023-12-31: revenue of $243.80 million, net income (loss) -$27.26 million (10-K, 2026-02-27).

Updated Oct 25, 2026 ET

Aebi schmidt holding ag news

This section ties “Aebi schmidt holding ag news” to Aebi Schmidt Holding AG (ticker AEBI), SEC Central Index Key 2048519, an EDGAR registrant classified as “Construction Machinery & Equip” and organised in Switzerland. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K/A dated 2026-09-25. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-19 by Aebi Schmidt Holding AG (CIK 2048519) — source document:

Aebi Schmidt Holdings AG is a leading global manufacturer of specialty vehicles. We are headquartered in Switzerland and employ around 5,700 people. We operate in 17 countries through our own sales and service organizations, with more than 70 locations worldwide, including over a dozen production facilities and a dense network of upfitting and service centers. Through established partnerships with dealers, we are represented in more than 90 additional countries globally. Our core offerings include solutions and equipment for snow removal and de-icing, street and runway sweepers, truck and recreational vehicle (“RV”) chassis, as well as truck bodies and vehicle upfitting for a wide range of commercial fleets and vocations. Furthermore, we produce specialty vehicles and equipment for municipal and airport maintenance services as well as for the cultivation of steep and challenging terrain.

Financial trend for Aebi Schmidt Holding AG from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $1.02 billion (2023-12-31) to $1.53 billion (2025-12-31), a change of +50.3%; net income (loss) went from $11.20 million (2023-12-31) to $9.74 million (2025-12-31), a change of -13.0%; total assets went from $1.09 billion (2024-12-31) to $2.01 billion (2025-12-31), a change of +84.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2048519, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Aebi Schmidt Holding AG did not tag for that period.

For the latest news, the fastest official source is the filing feed: Aebi Schmidt Holding AG (CIK 2048519) filed 13 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-13, and its overall latest filing is a 8-K/A dated 2026-09-25. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 13 8-K or 6-K reports in Aebi Schmidt Holding AG’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-08-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2048519 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2024-12-16. Insider trades for Aebi Schmidt Holding AG appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Alliance resource partners arlp news october 2026

This section ties “Alliance resource partners arlp news october 2026” to ALLIANCE RESOURCE PARTNERS LP (ticker ARLP), SEC Central Index Key 1086600, an EDGAR registrant classified as “Bituminous Coal & Lignite Surface Mining” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 144 dated 2026-09-15. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-26 by ALLIANCE RESOURCE PARTNERS LP (CIK 1086600) — source document:

Our core objective is to maximize the value of our mineral asset base—both through coal production from our mining operations and through the leasing and development of our coal and oil & gas mineral interests. Our strategy is to provide reliable, baseload fuel for electricity generating customers while positioning the Partnership for long-term growth through investments in energy and related infrastructure. Leveraging our relationships with electric utilities, industrial customers, and government partners, we intend to pursue strategic opportunities that complement our operational strengths. We believe our diverse resource portfolio and targeted investments will continue to create long-term value for our unitholders. ​ We are the second largest coal producer in the eastern United States and as of December 31, 2025, we operated seven underground mining complexes across Illinois, Indiana, Kentucky, Maryland, Pennsylvania, and West Virginia and a coal-loading terminal on the Ohio River in Indiana.

Financial trend for ALLIANCE RESOURCE PARTNERS LP from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $586.20 million (2022-12-31) to $311.16 million (2025-12-31), a change of -46.9%; total assets went from $2.73 billion (2022-12-31) to $2.85 billion (2025-12-31), a change of +4.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1086600, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures ALLIANCE RESOURCE PARTNERS LP did not tag for that period.

For the latest news, the fastest official source is the filing feed: ALLIANCE RESOURCE PARTNERS LP (CIK 1086600) filed 118 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-07-27, and its overall latest filing is a 144 dated 2026-09-15. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 118 8-K or 6-K reports in ALLIANCE RESOURCE PARTNERS LP’s recent EDGAR index, the 4 listed here run from 2026-06-08 to 2026-07-27, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1086600 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2012-08-16. Insider trades for ALLIANCE RESOURCE PARTNERS LP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Aosl alpha omega semiconductor october 2026 news

This section ties “Aosl alpha omega semiconductor october 2026 news” to ALPHA & OMEGA SEMICONDUCTOR Ltd (ticker AOSL), SEC Central Index Key 1387467, an EDGAR registrant classified as “Semiconductors & Related Devices” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a ARS dated 2026-09-30, and this view starts from filings dated on or before 2026-08-07. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-08-27 by ALPHA & OMEGA SEMICONDUCTOR Ltd (CIK 1387467) (passage 2, continuing from the earlier excerpt) — source document:

We have an extensive patent portfolio that consists of 961 issued patents and 78 pending patents in the United States as of June 30, 2026. We also have a total of 991 foreign patents, which were based primarily on our research and development efforts through June 30, 2026. We differentiate ourselves by integrating our expertise in technology, design and advanced manufacturing and packaging to optimize product performance and cost. Our portfolio of products targets high-volume applications, including personal computers, graphic cards, game consoles, home appliances, power tools, smart phones, battery packs, consumer and industrial motor controls and power supplies for computers, servers and telecommunications equipment. During the fiscal year ended June 30, 2026, we continued our diversification strategy by developing new silicon and packaging platforms to expand our serviceable available market, or SAM, and offer higher performance products.

Financial trend for ALPHA & OMEGA SEMICONDUCTOR Ltd from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-03-31: net income (loss) went from -$2.12 million (2025-09-30) to -$13.79 million (2026-03-31), a change of -549.7%; total assets went from $1.04 billion (2025-09-30) to $976.41 million (2026-03-31), a change of -5.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1387467, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures ALPHA & OMEGA SEMICONDUCTOR Ltd did not tag for that period.

Current reports. Of the 142 8-K or 6-K reports in ALPHA & OMEGA SEMICONDUCTOR Ltd’s recent EDGAR index, the 4 listed here run from 2025-11-17 to 2026-04-17, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1387467 is on the EDGAR company page; the latest 10-K there is dated 2026-08-27 and the oldest filing in the recent index dates from 2007-01-16. One example from this record is the 4 filed 2026-09-11 (document). Insider trades for ALPHA & OMEGA SEMICONDUCTOR Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ardagh metal packaging s.a. bullish and bearish analyst opinions

This section ties “Ardagh metal packaging s.a. bullish and bearish analyst opinions” to Ardagh Metal Packaging S.A. (ticker AMBP), SEC Central Index Key 1845097, an EDGAR registrant classified as “Metal Cans” and organised in Luxembourg. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-22. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-05 by Ardagh Metal Packaging S.A. (CIK 1845097) — source document:

Operating and Financial Review and Prospects ​ 53 Item 6. Directors, Senior Management and Employees ​ 74 Item 7. Major Shareholders and Related Party Transactions ​ 83 Item 8. Financial Information ​ 87 Item 9. The Offer and Listing ​ 88 Item 10. Additional Information ​ 89 Item 11. Quantitative and Qualitative Disclosures About Market Risk ​ 97 Item 12. Description of Securities Other than Equity Securities ​ 99 Part II ​ 99 Item 13. Defaults, Dividend Arrearages and Delinquencies ​ 99 Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds ​ 99 Item 15. Controls and Procedures ​ 100 Item 16. Reserved ​ 101 Item 16A. Audit committee financial expert ​ 101 Item 16B. Code of Ethics ​ 101 Item 16C. Principal Accountant Fees and Services ​ 102 Item 16D. Exemptions from the Listing Standards for Audit Committees ​ 102 Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers ​ 102 Item 16F. Changes in Registrant’s Certifying Accountant ​ 103 Item 16G. Corporate Governance ​ 103 Item 16H. Mine Safety Disclosure ​ 104 Item 16I.

Financial trend for Ardagh Metal Packaging S.A. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from 224,000,000 EUR (2022-12-31) to 10,000,000 EUR (2025-12-31), a change of -95.5%; total assets went from $5.87 billion (2022-12-31) to $5.68 billion (2025-12-31), a change of -3.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1845097, tags Assets, ProfitLoss; 4 periods shown, dashes mark figures Ardagh Metal Packaging S.A. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Ardagh Metal Packaging S.A. (CIK 1845097) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-03-05. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 100 8-K or 6-K reports in Ardagh Metal Packaging S.A.’s recent EDGAR index, the 4 listed here run from 2026-10-15 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1845097 is on the EDGAR company page; the latest 20-F there is dated 2026-03-05 and the oldest filing in the recent index dates from 2021-02-23. Insider trades for Ardagh Metal Packaging S.A. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ascentage

This section ties “Ascentage” to ASCENTAGE PHARMA GROUP INTERNATIONAL (ticker AAPG), SEC Central Index Key 2023311, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-22, and this view starts from filings dated on or before 2026-07-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-29 by ASCENTAGE PHARMA GROUP INTERNATIONAL (CIK 2023311) (passage 2, continuing from the earlier excerpt) — source document:

Shengda Taizhou held the equity interest in Ascentage Jiangsu for the benefit of Dr. Yang, Dr. Guo, Dr. Wang and Dr. Zhai. In December 2016, Ascentage Jiangsu entered into a share transfer agreement for the acquisition of the entire equity interest of Guangzhou Healthquest Pharma Co., Ltd., or Healthquest Pharma from Dr. Zhai and Ren Jing. See “ Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Healthquest acquisition. ” In November 2017, we commenced a reorganization, or the Reorganization, consisting of the following principal steps: 1. In November 2017, Ascentage Pharma Group International was incorporated as an exempted company with limited liability under the laws of the Cayman Islands; 2.

Financial trend for ASCENTAGE PHARMA GROUP INTERNATIONAL from annual reports, periods 2022-12-31 to 2024-12-31: revenue went from 209,711,000 CNY (2022-12-31) to 980,650,000 CNY (2024-12-31), a change of +367.6%; net income (loss) went from -882,924,000 CNY (2022-12-31) to -405,680,000 CNY (2024-12-31), a change of +54.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2023311, tags ProfitLoss, Revenue; 3 periods shown, dashes mark figures ASCENTAGE PHARMA GROUP INTERNATIONAL did not tag for that period.

ASCENTAGE PHARMA GROUP INTERNATIONAL has 131 filings in its recent EDGAR index, including 2 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-22.

Current reports. Of the 76 8-K or 6-K reports in ASCENTAGE PHARMA GROUP INTERNATIONAL’s recent EDGAR index, the 4 listed here run from 2026-08-05 to 2026-09-17, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2023311 is on the EDGAR company page; the latest 20-F there is dated 2026-04-29 and the oldest filing in the recent index dates from 2024-06-14. One example from this record is the 6-K filed 2026-09-17 (document). Insider trades for ASCENTAGE PHARMA GROUP INTERNATIONAL appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Asiastrategy bullish and bearish analyst opinions

This section ties “Asiastrategy bullish and bearish analyst opinions” to AsiaStrategy (ticker SORA), SEC Central Index Key 2033515, an EDGAR registrant classified as “Wholesale-Jewelry, Watches, Precious Stones & Metals” and organised in Cayman Islands, formerly known as Top Win International Ltd. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-06. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-30 by AsiaStrategy (CIK 2033515) — source document:

Top Win International Limited) was incorporated as a Cayman Islands exempted company with limited liability on June 27, 2024 under the laws of the Cayman Islands to serve as the holding company of our group for our listing on Nasdaq. As of the date of this annual report, AsiaStrategy is authorized to issue a maximum of 100,000,000 Ordinary Shares of par value US$0.0005 each, of which 24,864,000 Ordinary Shares are issued and outstanding. The Ordinary Shares offered in this annual report are those of AsiaStrategy. AsiaStrategy is a holding company and is not actively engaged in any business, and it conducts operations through our main Operating Subsidiary, namely Top Win International Trading Limited (“Top Win Hong Kong”) incorporated under the laws of Hong Kong, as well as other of our holding companies.

Financial trend for AsiaStrategy from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $14.23 million (2022-12-31) to $10.99 million (2025-12-31), a change of -22.8%; net income (loss) went from $71,990 (2022-12-31) to $12.29 million (2025-12-31), a change of +16976.9%; total assets went from $5.57 million (2023-12-31) to $39.72 million (2025-12-31), a change of +613.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2033515, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures AsiaStrategy did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on AsiaStrategy (CIK 2033515) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 29 8-K or 6-K reports in AsiaStrategy’s recent EDGAR index, the 4 listed here run from 2026-08-17 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2033515 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2024-08-16. Insider trades for AsiaStrategy appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Atrium mortgage investment corporation bullish and bearish analyst opinions

What this search refers to. Atrium Mortgage Investment Corporation is a Canadian non-bank mortgage lender listed on the Toronto Stock Exchange; it reports through SEDAR+ under Canadian securities law. Official source: www.sedarplus.ca.

No SEC filer could be matched to “Atrium mortgage investment corporation bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Atrium mortgage investment corporation” appears in 54 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “atrium” (search terms considered: atrium, mortgage, investment, corporation).

A broader EDGAR full-text search for the shorter phrase “Atrium mortgage investment” finds 654+ filing documents; among the top 100, the filers mentioning it most are AMERICAN CENTURY ETF TRUST (CIK 0001710607) (63); SPDR INDEX SHARES FUNDS (CIK 0001168164) (22); CANADIAN DERIVATIVES CLEARING CORP (CIK 0000319643) (7). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 54 most relevant full-text hits returned for “Atrium mortgage investment corporation”, filings range from 2013-05-01 to 2026-10-07. The filers whose documents mention it most often are AMERICAN CENTURY ETF TRUST (CIK 0001710607) (10 hits); SPDR INDEX SHARES FUNDS (CIK 0001168164) (10 hits); Swisher Hygiene Inc. (CIK 0001504747) (8 hits); BARRICK GOLD CORP (GOLD) (CIK 0000756894) (7 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 58 entities whose registered name contains the word “atrium”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “atrium” 58, “mortgage” 491, “investment” 484, “corporation” 486. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “atrium” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Bilibili.com (smart ring or ai recorder or smart contact lens or wearable) recommendation

This section ties “Bilibili.com (smart ring or ai recorder or smart contact lens or wearable) recommendation” to Bilibili Inc. (ticker BILI, BLBLF), SEC Central Index Key 1723690, an EDGAR registrant classified as “Services-Computer Processing & Data Preparation” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-08. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-16 by Bilibili Inc. (CIK 1723690) — source document:

Our website was first launched in June 2009 and was officially named “bilibili” in January 2010. We commenced our commercial operations in 2011 and established Shanghai Hode Information Technology Co., Ltd., which we refer to as Hode Information Technology in this annual report, to expand our operations in May 2013. Subsequently, we obtained control over Shanghai Kuanyu Digital Technology Co., Ltd., which we refer to as Shanghai Kuanyu in this annual report, in July 2014 to further expand our operations. We incorporated Bilibili Inc. under the laws of the Cayman Islands, an exempted company with limited liability, as our offshore holding company in December 2013. In February 2014, we established Hode HK Limited, or Hode HK, a wholly owned Hong Kong subsidiary.

Financial trend for Bilibili Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 21,899,167,000 CNY (2022-12-31) to 30,347,766,000 CNY (2025-12-31), a change of +38.6%; net income (loss) went from -4,822,321,000 CNY (2023-12-31) to 1,193,531,000 CNY (2025-12-31), a change of +124.8%; total assets went from 41,830,570,000 CNY (2022-12-31) to 41,167,763,000 CNY (2025-12-31), a change of -1.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1723690, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Bilibili Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Bilibili Inc. (CIK 1723690) lists its business address as 17TH FLOOR, BUILDING 3, GUOZHENG CENTER, SHANGHAI, which helps confirm you are on the right company’s site.

Current reports. Of the 221 8-K or 6-K reports in Bilibili Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-16 to 2026-10-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1723690 is on the EDGAR company page; the latest 20-F there is dated 2026-04-16 and the oldest filing in the recent index dates from 2017-12-15. Insider trades for Bilibili Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cardinal infrastructure group cdnl latest news october 2026

This section ties “Cardinal infrastructure group cdnl latest news october 2026” to Cardinal Infrastructure Group Inc. (ticker CDNL), SEC Central Index Key 2079999, an EDGAR registrant classified as “Heavy Construction Other Than Bldg Const - Contractors” and organised in DE, formerly known as Civil Infrastructure Group Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G dated 2026-10-19. Nothing here is a recommendation to trade the security.

Financial trend for Cardinal Infrastructure Group Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $247.92 million (2023-12-31) to $456.05 million (2025-12-31), a change of +83.9%; net income (loss) went from $20.57 million (2023-12-31) to $22.69 million (2025-12-31), a change of +10.3%; total assets went from $140.31 million (2024-12-31) to $394.59 million (2025-12-31), a change of +181.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2079999, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerIncludingAssessedTax; 3 periods shown, dashes mark figures Cardinal Infrastructure Group Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Cardinal Infrastructure Group Inc. (CIK 2079999) filed 11 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-19, and its overall latest filing is a SCHEDULE 13G dated 2026-10-19. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 11 8-K or 6-K reports in Cardinal Infrastructure Group Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-11 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 99 recent EDGAR filings, Cardinal Infrastructure Group Inc. most often filed 4 (24), SCHEDULE 13G (13), 3 (12), 8-K (11). A selection from 2026-08-17 to 2026-10-19:

The full record for CIK 2079999 is on the EDGAR company page; the latest 10-K there is dated 2026-03-23 and the oldest filing in the recent index dates from 2025-08-08. Insider trades for Cardinal Infrastructure Group Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cartesian therapeutics descartes-08 october 2026

This section ties “Cartesian therapeutics descartes-08 october 2026” to Cartesian Therapeutics, Inc. (ticker RNAC), SEC Central Index Key 1453687, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as SELECTA BIOSCIENCES INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-29, and this view starts from filings dated on or before 2026-01-06. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-09 by Cartesian Therapeutics, Inc. (CIK 1453687) (passage 5, continuing from the earlier excerpt) — source document:

Additionally, some patients experience an initial improvement but later lose response, requiring adjustments in their treatment strategy. Biologic therapies used for MG can increase the risk of infections. Complement inhibitors in particular, heighten susceptibility to Neisseria infections, necessitating vaccination and, in some cases, prophylactic antibiotic use. Patients receiving FcRn inhibitors may also experience an increased risk of infections due to immunoglobulin depletion. The long-term safety of these treatments remain an area of active study. Currently approved biologic therapies require frequent infusions, which can be burdensome for patients. Efgartigimod (Vyvgart) and rozanolixizumab (Rystiggo) both require weekly infusions in repeated cycles, while zilucoplan (Zilbrysq) is administered daily, both nipocalimab-aahu (Imaavy) and eculizumab (Soliris) are administered every two weeks, ravulizumab (Ultomiris) every eight weeks for most body weights and inebilizumab-cdon (Uplizna) every six months following two initial doses.

Financial trend for Cartesian Therapeutics, Inc. from annual reports, periods 2015-12-31 to 2018-01-01: revenue went from $6.01 million (2015-12-31) to $207,000 (2017-12-31), a change of -96.6%; net income (loss) went from -$25.17 million (2015-12-31) to -$65.32 million (2017-12-31), a change of -159.5%; total assets went from $42.82 million (2015-12-31) to $101.10 million (2018-01-01), a change of +136.1%. Values are as filed and not adjusted for restatements, splits or currency.

Cartesian Therapeutics, Inc. has 874 filings in its recent EDGAR index, including 10 annual reports and 31 quarterly reports; its newest filing is a 8-K from 2026-09-29.

Current reports. Of the 172 8-K or 6-K reports in Cartesian Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2025-04-29 to 2025-06-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1453687 is on the EDGAR company page; the latest 10-K there is dated 2026-03-09 and the oldest filing in the recent index dates from 2009-01-05. One example from this record is the 8-K filed 2026-04-30 (document). Insider trades for Cartesian Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

China everbright limited bullish and bearish analyst opinions

Read from its name, “China everbright limited” is a a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada) entity — “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. Its accounts and exchange notices are published through that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) (www.hkexnews.hk); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “China everbright limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “China everbright limited” appears in 1402+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “everbright” (search terms considered: china, everbright).

In the 100 most relevant full-text hits returned for “China everbright limited”, filings range from 2008-03-31 to 2024-12-23. The filers whose documents mention it most often are Focus Media Holding LTD (CIK 0001330017) (19 hits); iSoftStone Holdings Ltd (CIK 0001500308) (18 hits); ADVISORS' INNER CIRCLE FUND (CIK 0000878719) (12 hits); Global X Funds (CIK 0001432353) (10 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

Word by word, the number of EDGAR registrant names containing each term of this search is: “china” 456, “everbright” 14. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

China Everbright Limited (Hong Kong stock code 165) is a cross-border asset manager and investor, distinct from China Everbright Environment Group (code 257) and from China Everbright Bank. None of these is an SEC registrant, so analyst opinion would come from Hong Kong brokers rather than U.S. filings, and its announcements and annual reports are posted on HKEXnews.

China resources double-crane pharmaceutical co.,ltd. bullish and bearish analyst opinions

“Co., Ltd.” is the English rendering used by limited companies across East Asia. The name “China resources double-crane pharmaceutical co.,ltd.” therefore points to a company organised in China, Taiwan, Korea or Japan, and its official disclosures are on the home-exchange disclosure system (SSE/SZSE in mainland China, MOPS in Taiwan, DART in Korea, EDINET in Japan) (mops.twse.com.tw), not on EDGAR.

No SEC filer could be matched to “China resources double-crane pharmaceutical co.,ltd. bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “China resources double-crane pharmaceutical co.,ltd.” appears in 4513+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “resources” (search terms considered: china, resources, double-crane, pharmaceutical).

A broader EDGAR full-text search for the shorter phrase “China resources double-crane” finds 5029+ filing documents; among the top 100, the filers mentioning it most are Krane Shares Trust (CIK 0001547576) (18); DBX ETF TRUST (CIK 0001503123) (18); BLACKROCK FUNDS (CIK 0000844779) (11). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “China resources double-crane pharmaceutical co.,ltd.”, filings range from 2012-11-29 to 2026-09-24. The filers whose documents mention it most often are DBX ETF TRUST (CIK 0001503123) (31 hits); WisdomTree Trust (CIK 0001350487) (13 hits); BLACKROCK FUNDS (CIK 0000844779) (11 hits); iShares, Inc. (CIK 0000930667) (7 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 190+ entities whose registered name contains the word “resources”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “china” 456, “resources” 478, “double-crane” 0, “pharmaceutical” 301. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “resources” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Coya therapeutics, inc. bullish and bearish analyst opinions

This section ties “Coya therapeutics, inc. bullish and bearish analyst opinions” to Coya Therapeutics, Inc. (ticker COYA), SEC Central Index Key 1835022, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-16 by Coya Therapeutics, Inc. (CIK 1835022) — source document:

All references in this report to "Coya," the "Company," "we," "us," or "our" mean Coya Therapeutics, Inc. unless stated otherwise or the context otherwise indicates. Overview We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (“Tregs”). Tregs are a subpopulation of T-lymphocytes consisting of CD4+CD25high hFOXP3+ cells that suppress inflammatory responses. Tregs were first discovered in 1995 by Dr. Shimon Sakaguchi and since their discovery multiple lines of research have contributed to elucidate Treg biology and its role in health and disease. Dr. Sakaguchi was the 2025 winner of the Nobel Prize in Physiology or Medicine. Tregs and their transcription factors have been shown to be essential to maintaining cellular homeostasis by regulating autoimmune and inflammatory responses and maintaining self-tolerance in mammals.

Financial trend for Coya Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2022-12-31) to $7.95 million (2025-12-31); net income (loss) went from -$12.24 million (2022-12-31) to -$21.23 million (2025-12-31), a change of -73.3%; total assets went from $8.40 million (2022-12-31) to $49.95 million (2025-12-31), a change of +495.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1835022, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Coya Therapeutics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Coya Therapeutics, Inc. (CIK 1835022) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 54 8-K or 6-K reports in Coya Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-11 to 2026-10-14, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1835022 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2021-01-05. Insider trades for Coya Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cve reports for cisco unity connection

This section ties “Cve reports for cisco unity connection” to CISCO SYSTEMS, INC. (ticker CSCO), SEC Central Index Key 858877, an EDGAR registrant classified as “Computer Communications Equipment” and organised in DE, formerly known as CISCO SYSTEMS, INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 13F-HR dated 2026-10-15, and this view starts from filings dated on or before 2026-09-11. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-09-02 by CISCO SYSTEMS, INC. (CIK 858877) (passage 3, continuing from the earlier excerpt) — source document:

Our website is www.cisco.com. Through a link on the Investor Relations section of our website, we make available the following filings as soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission (SEC) at sec.gov: our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. All such filings are available free of charge. The information published on our website, or any other website referenced herein, is not incorporated into this report. Available Information We intend to announce material information to the public through our Investor Relations website at https://investor.cisco.com, SEC filings, press releases, public conference calls, and public webcasts, including those made available or broadcast on our Investor Relations website and through third-party websites, such as our LinkedIn page and YouTube channel.

Financial trend for CISCO SYSTEMS, INC. from annual reports, periods 2019-07-27 to 2022-07-30: net income (loss) went from $11.62 billion (2019-07-27) to $11.81 billion (2022-07-30), a change of +1.6%; total assets went from $97.79 billion (2019-07-27) to $94.00 billion (2022-07-30), a change of -3.9%. Values are as filed and not adjusted for restatements, splits or currency.

Current reports. Of the 76 8-K or 6-K reports in CISCO SYSTEMS, INC.’s recent EDGAR index, the 4 listed here run from 2025-06-09 to 2025-10-17, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 858877 is on the EDGAR company page; the latest 10-K there is dated 2026-09-02 and the oldest filing in the recent index dates from 2020-06-19. One example from this record is the 4 filed 2026-09-18 (document). Insider trades for CISCO SYSTEMS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Danaos corporation dac latest news october 2026

This section ties “Danaos corporation dac latest news october 2026” to Danaos Corp (ticker DAC), SEC Central Index Key 1369241, an EDGAR registrant classified as “Deep Sea Foreign Transportation of Freight” and organised in Marshall Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-09. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-02-27 by Danaos Corp (CIK 1369241) — source document:

Operating and Financial Review and Prospects ​ 60 Item 6. Directors, Senior Management and Employees ​ 95 Item 7. Major Shareholders and Related Party Transactions ​ 102 Item 8. Financial Information ​ 109 Item 9. The Offer and Listing ​ 110 Item 10. Additional Information ​ 110 Item 11. Quantitative and Qualitative Disclosures About Market Risk ​ 125 Item 12. Description of Securities Other than Equity Securities ​ 125 PART II ​ 126 Item 13. Defaults, Dividend Arrearages and Delinquencies ​ 126 Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds ​ 126 Item 15. Controls and Procedures ​ 126 Item 16A. Audit Committee Financial Expert ​ 129 Item 16B. Code of Ethics ​ 129 Item 16C. Principal Accountant Fees and Services ​ 129 Item 16D. Exemptions from the Listing Standards for Audit Committees ​ 130 Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers ​ 130 Item 16F. Change in Registrant’s Certifying Accountant ​ 131 Item 16G. Corporate Governance ​ 131 Item 16H. Mine Safety Disclosure ​ 131 Item 16I.

Financial trend for Danaos Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $993.34 million (2022-12-31) to $1.04 billion (2025-12-31), a change of +4.9%; net income (loss) went from $559.21 million (2022-12-31) to $494.61 million (2025-12-31), a change of -11.6%; total assets went from $3.40 billion (2022-12-31) to $5.11 billion (2025-12-31), a change of +50.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1369241, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Danaos Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Danaos Corp (CIK 1369241) filed 117 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-09, and its overall latest filing is a 6-K dated 2026-10-09. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 117 8-K or 6-K reports in Danaos Corp’s recent EDGAR index, the 4 listed here run from 2026-05-12 to 2026-10-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1369241 is on the EDGAR company page; the latest 20-F there is dated 2026-02-27 and the oldest filing in the recent index dates from 2006-09-19. Insider trades for Danaos Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Energizer holdings enr latest news october 2026

This section ties “Energizer holdings enr latest news october 2026” to ENERGIZER HOLDINGS, INC. (ticker ENR), SEC Central Index Key 1632790, an EDGAR registrant classified as “Miscellaneous Electrical Machinery, Equipment & Supplies” and organised in MO, formerly known as Energizer SpinCo, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 3 dated 2026-10-02. Nothing here is a recommendation to trade the security.

Financial trend for ENERGIZER HOLDINGS, INC. from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $3.05 billion (2022-09-30) to $2.95 billion (2025-09-30), a change of -3.2%; net income (loss) went from -$231.50 million (2022-09-30) to $239.00 million (2025-09-30), a change of +203.2%; total assets went from $4.57 billion (2022-09-30) to $4.56 billion (2025-09-30), a change of -0.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1632790, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures ENERGIZER HOLDINGS, INC. did not tag for that period.

For the latest news, the fastest official source is the filing feed: ENERGIZER HOLDINGS, INC. (CIK 1632790) filed 138 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-04, and its overall latest filing is a 3 dated 2026-10-02. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 138 8-K or 6-K reports in ENERGIZER HOLDINGS, INC.’s recent EDGAR index, the 4 listed here run from 2026-02-03 to 2026-08-04, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 910 recent EDGAR filings, ENERGIZER HOLDINGS, INC. most often filed 4 (543), 8-K (138), SC 13G/A (48), 10-Q (34). A selection from 2026-08-04 to 2026-10-02:

The full record for CIK 1632790 is on the EDGAR company page; the latest 10-K there is dated 2025-11-18 and the oldest filing in the recent index dates from 2015-02-06. Insider trades for ENERGIZER HOLDINGS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ensign peak advisors private equity alternatives investment news

This section ties “Ensign peak advisors private equity alternatives investment news” to Ensign Peak Advisors, Inc (ticker none listed), SEC Central Index Key 1454984, an EDGAR registrant classified as “no SIC description” and organised in UT. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a N-PX dated 2026-08-28. Nothing here is a recommendation to trade the security.

For the latest news, the fastest official source is the filing feed: Ensign Peak Advisors, Inc (CIK 1454984) filed 0 current reports (8-K or 6-K) in its recent EDGAR window, and its overall latest filing is a N-PX dated 2026-08-28. Companies must file an 8-K within four business days of most material events.

What kind of filer this is matters for “Ensign peak advisors private equity alternatives investment news”: Ensign Peak Advisors, Inc’s EDGAR record from 2009-03-03 to 2026-08-28 consists only of 13F holdings reports as an institutional investment manager; 13F-HR/A filings; N-PX filings; N-PX/A filings; SC 13G/A filings; Schedule 13G ownership reports, filed when it held more than 5% of another company’s shares. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Other filings. Across its 37 recent EDGAR filings, Ensign Peak Advisors, Inc most often filed 13F-HR (27), N-PX (3), 13F-HR/A (3), SC 13G (2). A selection from 2026-08-14 to 2026-08-28:

The full record for CIK 1454984 is on the EDGAR company page and the oldest filing in the recent index dates from 2009-03-03. Insider trades for Ensign Peak Advisors, Inc appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

General dynamics rtx boeing defense merger acquisition export policy latest

Three defence primes searched together for mergers, acquisitions and export-policy news. Each company named is a separate SEC registrant reporting on its own; filing data as of Oct 25, 2026.

GENERAL DYNAMICS CORP (GD; ship & boat building & repairing, incorporated in DE): its index shows the 8-K of 2026-08-04 covering 8.01 (other events), 9.01 (financial statements and exhibits); the 8-K of 2026-07-29 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits). Year to 2024-12-31: reported revenue $47.72 billion, bottom line $3.78 billion (10-K, 2026-01-30).

BOEING CO (BA; aircraft, incorporated in DE) — EDGAR lists the 8-K of 2026-08-28 covering 1.01 (entry into a material definitive agreement), 2.03 (creation of a direct financial obligation), 9.01 (financial statements and exhibits); the 8-K of 2026-08-21 covering 5.02 (departure/election of directors or officers). Year to 2025-12-31: annual sales of $89.46 billion, net result $2.23 billion (10-K, 2026-01-30).

RTX Corp (RTX; aircraft engines & engine parts, incorporated in DE) filed the 8-K of 2026-10-20 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2026-09-15 covering 5.02 (departure/election of directors or officers), 9.01 (financial statements and exhibits). Year to 2024-12-31: FY revenue tagged at $80.74 billion, profit or loss $4.77 billion (10-K, 2025-02-03).

Item 2.01 count (completion of an acquisition or disposition of assets): GD 0, BA 0, RTX 5 (latest 2020-04-08).

Updated Oct 25, 2026 ET

Gyrodyne, llc bullish and bearish analyst opinions

This section ties “Gyrodyne, llc bullish and bearish analyst opinions” to Gyrodyne, LLC (ticker GYRO), SEC Central Index Key 1589061, an EDGAR registrant classified as “Opeators of Nonresidential Buildings” and organised in NY. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-20, and this view starts from filings dated on or before 2025-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by Gyrodyne, LLC (CIK 1589061) (passage 2, continuing from the earlier excerpt) — source document:

Gyrodyne’s corporate strategy is to enhance the value of Flowerfield and Cortlandt Manor by pursuing entitlement opportunities to provide purchasers increased development flexibility, and by enhancing the value of our leases. The Board and Management believe the aforementioned strategy will increase the aggregate value for such properties as a whole. The value of the real estate reported in the consolidated statement of net assets as of December 31, 2025 and December 31, 2024 includes some, but not all of the potential value impact that may result from such value enhancement efforts. There can be no assurance that our value enhancement efforts will result in property value increases that exceed the costs we incur in such efforts, or even any increase at all.

Financial trend for Gyrodyne, LLC from annual reports, periods 2014-12-31 to 2025-12-31: revenue was tagged only for 2014-12-31 at $2.80 million; net income (loss) was tagged only for 2014-12-31 at -$3.11 million; total assets went from $43.88 million (2014-12-31) to $58.69 million (2025-12-31), a change of +33.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1589061, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Gyrodyne, LLC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Gyrodyne, LLC (CIK 1589061) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 50 8-K or 6-K reports in Gyrodyne, LLC’s recent EDGAR index, the 4 listed here run from 2024-10-16 to 2025-11-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1589061 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2013-10-21. One example from this record is the 10-Q filed 2026-05-13 (document). Insider trades for Gyrodyne, LLC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Harrow inc hrow latest news october 2026

This section ties “Harrow inc hrow latest news october 2026” to HARROW, INC. (ticker HROW), SEC Central Index Key 1360214, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as HARROW HEALTH, INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-05, and this view starts from filings dated on or before 2025-11-10. Nothing here is a recommendation to trade the security.

Financial trend for HARROW, INC. from annual reports, periods 2014-12-31 to 2017-12-31: revenue was tagged only for 2017-12-31 at $26.77 million; net income (loss) went from -$10.12 million (2014-12-31) to -$11.98 million (2017-12-31), a change of -18.5%; total assets went from $10.24 million (2014-12-31) to $23.92 million (2017-12-31), a change of +133.5%. Values are as filed and not adjusted for restatements, splits or currency.

Current reports. Of the 268 8-K or 6-K reports in HARROW, INC.’s recent EDGAR index, the 4 listed here run from 2025-09-19 to 2025-09-29, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 867 recent EDGAR filings, HARROW, INC. most often filed 8-K (268), 4 (237), 10-Q (56), 3 (42). A selection from 2025-12-16 to 2026-03-02:

The full record for CIK 1360214 is on the EDGAR company page; the latest 10-K there is dated 2026-03-02 and the oldest filing in the recent index dates from 2006-07-21. One example from this record is the 4 filed 2026-05-19 (document). Insider trades for HARROW, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Hasi ha sustainable infrastructure latest news october 2026

This section ties “Hasi ha sustainable infrastructure latest news october 2026” to HA Sustainable Infrastructure Capital, Inc. (ticker HASI), SEC Central Index Key 1561894, an EDGAR registrant classified as “Investors, NEC” and organised in DE, formerly known as Hannon Armstrong Sustainable Infrastructure Capital, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 424B3 dated 2026-08-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-13 by HA Sustainable Infrastructure Capital, Inc. (CIK 1561894) — source document:

HASI is an investor in sustainable infrastructure assets advancing the energy transition. Our investment strategy is focused on actively partnering with clients to deploy capital primarily in income-generating real assets that are supported by long-term recurring cash flows. This strategy has enabled us to generate attractive risk-adjusted returns and provide stockholders with diversified exposure to the energy transition. We are internally managed by an executive team that has extensive relevant industry knowledge and experience, and oversees a team of over 170 full-time investment, operating, and technical professionals. We have long-standing, programmatic relationships with some of the leading U.S. clean energy project developers, owners and operators, utilities, and energy service companies, which provide recurring, investment and fee-generating opportunities, while also enabling scale benefits and operational and transactional efficiencies.

Financial trend for HA Sustainable Infrastructure Capital, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $239.74 million (2022-12-31) to $400.50 million (2025-12-31), a change of +67.1%; net income (loss) went from $41.50 million (2022-12-31) to $184.55 million (2025-12-31), a change of +344.7%; total assets went from $4.76 billion (2022-12-31) to $8.19 billion (2025-12-31), a change of +72.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1561894, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures HA Sustainable Infrastructure Capital, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: HA Sustainable Infrastructure Capital, Inc. (CIK 1561894) filed 190 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-06, and its overall latest filing is a 424B3 dated 2026-08-19. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 190 8-K or 6-K reports in HA Sustainable Infrastructure Capital, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-15 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1561894 is on the EDGAR company page; the latest 10-K/A there is dated 2026-03-26 and the oldest filing in the recent index dates from 2013-04-17. Insider trades for HA Sustainable Infrastructure Capital, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Hemab therapeutics ceo press release

This section ties “Hemab therapeutics ceo press release” to Hemab Therapeutics Holdings, Inc. (ticker COAG), SEC Central Index Key 2114044, an EDGAR registrant classified as “Biological Products, (No Diagnostic Substances)” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-25, and this view starts from filings dated on or before 2026-02-27. Nothing here is a recommendation to trade the security.

Other filings. Across its 50 recent EDGAR filings, Hemab Therapeutics Holdings, Inc. most often filed 3 (12), 4 (10), SCHEDULE 13G (8), 8-K (5). A selection from 2026-04-30 to 2026-04-30:

The full record for CIK 2114044 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-02-27. One example from this record is the 3 filed 2026-05-14 (document). Insider trades for Hemab Therapeutics Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Hydrofarm holdings group, inc. bullish and bearish analyst opinions

This section ties “Hydrofarm holdings group, inc. bullish and bearish analyst opinions” to HYDROFARM HOLDINGS GROUP, INC. (ticker HYFM), SEC Central Index Key 1695295, an EDGAR registrant classified as “Wholesale-Miscellaneous Nondurable Goods” and organised in DE, formerly known as Innovation Acquisition One Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-09. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by HYDROFARM HOLDINGS GROUP, INC. (CIK 1695295) — source document:

We are a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture ("CEA"), including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative and proprietary branded products. We primarily serve the U.S. and Canadian markets, and believe we are one of the leading companies in these markets in an otherwise fragmented industry. For over 40 years, we have helped growers make growing easier and more productive. Our mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency, and speed in their grow projects. For the 2025 fiscal year, our net sales were $134.3 million.

Financial trend for HYDROFARM HOLDINGS GROUP, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $344.50 million (2022-12-31) to $134.25 million (2025-12-31), a change of -61.0%; net income (loss) went from -$285.42 million (2022-12-31) to -$289.79 million (2025-12-31), a change of -1.5%; total assets went from $573.56 million (2022-12-31) to $123.80 million (2025-12-31), a change of -78.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1695295, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures HYDROFARM HOLDINGS GROUP, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on HYDROFARM HOLDINGS GROUP, INC. (CIK 1695295) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-14, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 65 8-K or 6-K reports in HYDROFARM HOLDINGS GROUP, INC.’s recent EDGAR index, the 4 listed here run from 2026-07-09 to 2026-10-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1695295 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2017-04-25. Insider trades for HYDROFARM HOLDINGS GROUP, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jena acquisition corporation ii bullish and bearish analyst opinions

This section ties “Jena acquisition corporation ii bullish and bearish analyst opinions” to JENA ACQUISITION Corp II (ticker JENA, JENA-RI, JENA-UN), SEC Central Index Key 2060337, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands, formerly known as JENA ACQUISITION CORPORARTION II. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-14, and this view starts from filings dated on or before 2025-08-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-30 by JENA ACQUISITION Corp II (CIK 2060337) (passage 2, continuing from the earlier excerpt) — source document:

In identifying and evaluating target companies, we are capitalizing on the tactical, operational and organizational experience of our Co-Founders, William P. Foley, II and Richard N. Massey. We believe Mr. Foley’s and Mr. Massey’s distinguished and multi-decade track records in building, growing, operating and investing in businesses across the public and private markets can have a transformative impact on a target business. Although we may pursue targets in any business or industry, we are focusing our search on identifying a prospective target business in a business that fits within our Co-Founders’ historical areas of business expertise. Our Co-Founders’ long track record includes varied investments across financial technology, business services, entertainment & sports, consumer & retail (particularly wine and spirits), real estate, insurance and general financial institutions.

Other filings. Across its 39 recent EDGAR filings, JENA ACQUISITION Corp II most often filed 3 (7), 10-Q (4), 8-K (4), SCHEDULE 13G/A (4). A selection from 2025-08-13 to 2026-02-11:

The full record for CIK 2060337 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2025-04-07. One example from this record is the SCHEDULE 13G/A filed 2026-02-12 (document). Insider trades for JENA ACQUISITION Corp II appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jinxin fertility group limited bullish and bearish analyst opinions

The legal-form ending in “Jinxin fertility group limited” is the clue: “Limited” is the company form used across Hong Kong, Australia, Singapore and other Commonwealth markets. A company of that kind reports in a Commonwealth jurisdiction (most often Hong Kong, Australia, Singapore or Canada), so the place to read its annual report and announcements is that market’s exchange filing system (HKEXnews, ASX announcements, SGXNet or SEDAR+) — www.hkexnews.hk.

No SEC filer could be matched to “Jinxin fertility group limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Jinxin fertility group limited” appears in 990+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “jinxin” (search terms considered: jinxin, fertility).

A broader EDGAR full-text search for the shorter phrase “Jinxin fertility group” finds 7475+ filing documents; among the top 100, the filers mentioning it most are AMG FUNDS (CIK 0001089951) (18); Krane Shares Trust (CIK 0001547576) (12); BlackRock Health Sciences Trust II (BMEZ) (CIK 0001785971) (11). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Jinxin fertility group limited”, filings range from 2020-07-30 to 2026-10-23. The filers whose documents mention it most often are WELLS FARGO MASTER TRUST (CIK 0001087961) (14 hits); JNL SERIES TRUST (CIK 0000933691) (13 hits); John Hancock Funds II (CIK 0001331971) (10 hits); JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 0000756913) (9 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 2 entities whose registered name contains the word “jinxin”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “jinxin” 2, “fertility” 22. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “jinxin” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Knightscope kscp news october 2026 earnings product infrastructure

This section ties “Knightscope kscp news october 2026 earnings product infrastructure” to Knightscope, Inc. (ticker KSCP), SEC Central Index Key 1600983, an EDGAR registrant classified as “Communications Equipment, NEC” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-20, and this view starts from filings dated on or before 2026-06-09. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by Knightscope, Inc. (CIK 1600983) (passage 2, continuing from the earlier excerpt) — source document:

Human– on premise licensed security personnel and remote monitoring with human-in-the-loop verification, escalation, and response. ​ We deliver these components as an integrated managed service. By combining hardware, software, and human personnel into a unified operational framework, we seek to provide clients with end-to-end accountability rather than fragmented security tools. ​ Our capabilities currently focus on deterrence, detection, and reporting. We are in the process of evolving our service model to “Deter, Detect, Respond” including response capabilities, where appropriate and legally permissible. Response capabilities, when provided, are intended to be conducted by properly licensed personnel and subject to applicable federal, state, and local laws. ​ We believe that integrating humans as a delivery and operational mechanism for our autonomous systems enables our product suites to operate in a more multi-modal manner, consistent with how many clients structure security procurement with a multi-layer approach.

Financial trend for Knightscope, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $3.13 million (2025-09-30) to $9.02 million (2026-06-30), a change of +188.2%; net income (loss) went from -$9.54 million (2025-09-30) to -$14.09 million (2026-06-30), a change of -47.7%; total assets went from $41.06 million (2025-09-30) to $55.93 million (2026-06-30), a change of +36.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1600983, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Knightscope, Inc. did not tag for that period.

For reported results, Knightscope, Inc.’s (CIK 1600983) latest 10-Q is dated 2026-08-12 and its latest annual report (10-K) 2026-03-27. Earnings releases appear as 8-K Item 2.02 filings; 6 are in the recent index, the newest on 2026-10-20.

Current reports. Of the 49 8-K or 6-K reports in Knightscope, Inc.’s recent EDGAR index, the 4 listed here run from 2026-03-03 to 2026-08-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1600983 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2014-02-27. One example from this record is the 8-K filed 2026-09-04 (document). Insider trades for Knightscope, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kyntra bio, inc. bullish and bearish analyst opinions

This section ties “Kyntra bio, inc. bullish and bearish analyst opinions” to KYNTRA BIO, INC. (ticker KYNB), SEC Central Index Key 921299, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in an unstated jurisdiction, formerly known as FIBROGEN INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-06. Nothing here is a recommendation to trade the security.

Financial trend for KYNTRA BIO, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $140.73 million (2022-12-31) to $6.44 million (2025-12-31), a change of -95.4%; net income (loss) went from -$293.65 million (2022-12-31) to $183.45 million (2025-12-31), a change of +162.5%; total assets went from $610.09 million (2022-12-31) to $119.59 million (2025-12-31), a change of -80.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 921299, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures KYNTRA BIO, INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on KYNTRA BIO, INC. (CIK 921299) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-13, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 164 8-K or 6-K reports in KYNTRA BIO, INC.’s recent EDGAR index, the 4 listed here run from 2026-08-13 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1000 recent EDGAR filings, KYNTRA BIO, INC. most often filed 4 (605), 8-K (164), SC 13G/A (41), 10-Q (32). A selection from 2026-08-14 to 2026-10-06:

The full record for CIK 921299 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2016-02-18. Insider trades for KYNTRA BIO, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Loma negra compañía industrial argentina sociedad anónima bullish and bearish analyst opinions

This section ties “Loma negra compañía industrial argentina sociedad anónima bullish and bearish analyst opinions” to Loma Negra Compania Industrial Argentina Sociedad Anonima (ticker LOMA), SEC Central Index Key 1711375, an EDGAR registrant classified as “Cement, Hydraulic” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-28 by Loma Negra Compania Industrial Argentina Sociedad Anonima (CIK 1711375) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 66 A. Operating Results 66 B. Liquidity and Capital Resources 97 C. Research and Development, Patents and Licenses, etc. 102 D. Trend Information 103 E. Critical Accounting Estimates 103 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 103 A. Directors and Senior Management 103 B. Compensation 108 C. Board Practices 111 D. Employees 115 E. Share Ownership 115 F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 116 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 116 A. Major Shareholders 116 B. Related Party Transactions 117 C. Interests of Experts and Counsel 118 ITEM 8. FINANCIAL INFORMATION 118 A. Consolidated Statements and Other Financial Information 118 B. Significant Changes 123 ITEM 9.

Financial trend for Loma Negra Compania Industrial Argentina Sociedad Anonima from annual reports, periods 2021-12-31 to 2024-12-31: revenue went from 446,871,607,000 ARS (2021-12-31) to 699,178,686,000 ARS (2024-12-31), a change of +56.5%; net income (loss) went from 38,483,507,000 ARS (2021-12-31) to 153,626,515,000 ARS (2024-12-31), a change of +299.2%; total assets went from 204,242,567,000 ARS (2021-12-31) to 1,408,332,054,000 ARS (2024-12-31), a change of +589.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1711375, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Loma Negra Compania Industrial Argentina Sociedad Anonima did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Loma Negra Compania Industrial Argentina Sociedad Anonima (CIK 1711375) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-28. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 293 8-K or 6-K reports in Loma Negra Compania Industrial Argentina Sociedad Anonima’s recent EDGAR index, the 4 listed here run from 2026-08-06 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1711375 is on the EDGAR company page; the latest 20-F there is dated 2026-04-28 and the oldest filing in the recent index dates from 2017-07-12. Insider trades for Loma Negra Compania Industrial Argentina Sociedad Anonima appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lxp industrial trust bullish and bearish analyst opinions

This section ties “Lxp industrial trust bullish and bearish analyst opinions” to LXP Industrial Trust (ticker LXP, LXP-PC), SEC Central Index Key 910108, an EDGAR registrant classified as “Real Estate Investment Trusts” and organised in MD, formerly known as LEXINGTON REALTY TRUST. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a DEFA14A dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-12 by LXP Industrial Trust (CIK 910108) — source document:

We are a Maryland real estate investment trust, qualified as a REIT for federal income tax purposes, focused on Class A warehouse and distribution real estate investments in target markets in the Sunbelt and lower Midwest. Class A real estate encompasses attractive and efficient buildings of high quality that are well-designed and constructed with above-average material, workmanship and finishes and are well-maintained and managed. A majority of our properties are subject to net or similar leases, where the tenant bears all or substantially all of the costs, including cost increases, for real estate taxes, utilities, insurance and ordinary repairs. However, certain leases provide that the landlord is responsible for certain operating expenses.

Financial trend for LXP Industrial Trust from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $321.25 million (2022-12-31) to $350.23 million (2025-12-31), a change of +9.0%; net income (loss) went from $113.78 million (2022-12-31) to $113.16 million (2025-12-31), a change of -0.5%; total assets went from $4.05 billion (2022-12-31) to $3.54 billion (2025-12-31), a change of -12.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 910108, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures LXP Industrial Trust did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on LXP Industrial Trust (CIK 910108) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-07-29, and the most recent 10-K annual report was filed 2026-02-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 155 8-K or 6-K reports in LXP Industrial Trust’s recent EDGAR index, the 4 listed here run from 2026-06-01 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 910108 is on the EDGAR company page; the latest 10-K there is dated 2026-02-12 and the oldest filing in the recent index dates from 2013-10-03. Insider trades for LXP Industrial Trust appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Metagenomi, inc. common stock bullish and bearish analyst opinions

This section ties “Metagenomi, inc. common stock bullish and bearish analyst opinions” to Metagenomi Therapeutics, Inc. (ticker MGX), SEC Central Index Key 1785279, an EDGAR registrant classified as “Biological Products, (No Diagnostic Substances)” and organised in an unstated jurisdiction, formerly known as Metagenomi, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-22. Nothing here is a recommendation to trade the security.

Financial trend for Metagenomi Therapeutics, Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $44.76 million (2023-12-31) to $25.21 million (2025-12-31), a change of -43.7%; net income (loss) went from -$68.25 million (2023-12-31) to -$87.87 million (2025-12-31), a change of -28.7%; total assets went from $364.84 million (2023-12-31) to $221.10 million (2025-12-31), a change of -39.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1785279, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Metagenomi Therapeutics, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Metagenomi Therapeutics, Inc. (CIK 1785279) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-10, and the most recent 10-K annual report was filed 2026-03-05. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 23 8-K or 6-K reports in Metagenomi Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-11 to 2026-09-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 154 recent EDGAR filings, Metagenomi Therapeutics, Inc. most often filed 4 (58), 8-K (23), 3 (15), 10-Q (8). A selection from 2026-09-10 to 2026-09-11:

The full record for CIK 1785279 is on the EDGAR company page; the latest 10-K there is dated 2026-03-05 and the oldest filing in the recent index dates from 2019-08-16. Insider trades for Metagenomi Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Micropolis ai robotics sec filing october 2026

This section ties “Micropolis ai robotics sec filing october 2026” to Micropolis AI Robotics (ticker MCRP), SEC Central Index Key 1993431, an EDGAR registrant classified as “Motor Vehicle Parts & Accessories” and organised in Cayman Islands, formerly known as Micropolis Holding Co. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-23, and this view starts from filings dated on or before 2026-02-27. Nothing here is a recommendation to trade the security.

Micropolis AI Robotics has 71 filings in its recent EDGAR index, including 1 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-23.

Current reports. Of the 17 8-K or 6-K reports in Micropolis AI Robotics’s recent EDGAR index, the 4 listed here run from 2025-10-23 to 2025-11-25, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 71 recent EDGAR filings, Micropolis AI Robotics most often filed 6-K (17), F-1/A (8), CORRESP (8), 3 (7). A selection from 2026-03-18 to 2026-03-18:

The full record for CIK 1993431 is on the EDGAR company page; the latest 20-F there is dated 2025-05-08 and the oldest filing in the recent index dates from 2023-10-13. One example from this record is the NT 20-F filed 2026-04-29 (document). Insider trades for Micropolis AI Robotics appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mountain crest acquisition corp. v bullish and bearish analyst opinions

This section ties “Mountain crest acquisition corp. v bullish and bearish analyst opinions” to Mountain Crest Acquisition Corp. V (ticker MCAG, MCAGR, MCAGU), SEC Central Index Key 1859035, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a DEFM14A dated 2026-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-16 by Mountain Crest Acquisition Corp. V (CIK 1859035) — source document:

In this Annual Report on Form 10-K (the “Form 10-K”), references to the “Company,” “Mountain Crest” and to “we,” “us,” and “our” refer to MOUNTAIN CREST ACQUISITION CORP. V Introduction We are a blank check company formed under the laws of the State of Delaware on April 8, 2021. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this annual report as our initial business combination. Although there is no restriction or limitation on what industry or geographic region our target operates in, it is our intention to pursue prospective targets that are in North America and Asia Pacific regions (excluding China).

Financial trend for Mountain Crest Acquisition Corp. V from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $4,471 (2022-12-31) to -$431,161 (2025-12-31), a change of -9743.5%; total assets went from $19.84 million (2022-12-31) to $873,566 (2025-12-31), a change of -95.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1859035, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Mountain Crest Acquisition Corp. V did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Mountain Crest Acquisition Corp. V (CIK 1859035) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-16. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Mountain Crest Acquisition Corp. V — registration statements, prospectuses and merger proxies — are filed on EDGAR; 26 such filings (424B4, 425, DEFM14A, S-1, S-1/A) appear in its recent index, the newest dated 2026-10-20.

Current reports. Of the 46 8-K or 6-K reports in Mountain Crest Acquisition Corp. V’s recent EDGAR index, the 4 listed here run from 2025-04-28 to 2025-12-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1859035 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2021-06-14. Insider trades for Mountain Crest Acquisition Corp. V appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nabors industries nbr latest news october 2026

This section ties “Nabors industries nbr latest news october 2026” to NABORS INDUSTRIES LTD (ticker NBR), SEC Central Index Key 1163739, an EDGAR registrant classified as “Drilling Oil & Gas Wells” and organised in Bermuda. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-02. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-13 by NABORS INDUSTRIES LTD (CIK 1163739) — source document:

Unless the context requires otherwise, references in this annual report to “we,” “us,” “our,” “the Company,” or “Nabors” mean Nabors Industries Ltd., together with our subsidiaries. References in this annual report to “Nabors Delaware” mean Nabors Industries, Inc., a wholly owned subsidiary of Nabors. ​ Overview ​ Nabors owns and operates one of the world’s largest land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and numerous international markets. Nabors also supplies performance software, tubular running services, managed pressure drilling services and innovative technologies for both its own rig fleet and those operated by third parties. In addition, Nabors manufactures advanced drilling equipment and provides drilling rig instrumentation.

Financial trend for NABORS INDUSTRIES LTD from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $2.65 billion (2022-12-31) to $3.18 billion (2025-12-31), a change of +20.0%; net income (loss) went from -$350.26 million (2022-12-31) to $286.62 million (2025-12-31), a change of +181.8%; total assets went from $4.73 billion (2022-12-31) to $4.79 billion (2025-12-31), a change of +1.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1163739, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures NABORS INDUSTRIES LTD did not tag for that period.

For the latest news, the fastest official source is the filing feed: NABORS INDUSTRIES LTD (CIK 1163739) filed 261 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-08, and its overall latest filing is a 4 dated 2026-10-02. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 261 8-K or 6-K reports in NABORS INDUSTRIES LTD’s recent EDGAR index, the 4 listed here run from 2026-07-28 to 2026-09-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1163739 is on the EDGAR company page; the latest 10-K there is dated 2026-02-13 and the oldest filing in the recent index dates from 2010-04-21. Insider trades for NABORS INDUSTRIES LTD appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Newbury pharmaceuticals ab (publ) bullish and bearish analyst opinions

The legal-form ending in “Newbury pharmaceuticals ab (publ)” is the clue: “AB (publ)” marks a Swedish public limited company (aktiebolag) allowed to offer shares to the public. A company of that kind reports in Sweden, so the place to read its annual report and announcements is Nasdaq Stockholm / Spotlight announcements and the Swedish FSA (Finansinspektionen) register — www.fi.se.

No SEC filer could be matched to “Newbury pharmaceuticals ab (publ) bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Newbury pharmaceuticals ab publ”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “newbury” (search terms considered: newbury, pharmaceuticals).

Even the shorter phrase “Newbury pharmaceuticals ab” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (newbury, pharmaceuticals) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in Sweden. Companies there file with Nasdaq Stockholm and Finansinspektionen rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “newbury” is therefore the Sweden regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 46 entities whose registered name contains the word “newbury”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “newbury” 46, “pharmaceuticals” 449. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “newbury” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Newel auctions jake baer 2026

What this search refers to. This 2026 query about Jake Baer and Newel concerns a private New York auction firm, so the current-year record is in the company’s own announcements and New York State business-entity records, not in EDGAR. Official source: apps.dos.ny.gov.

No SEC filer could be matched to “Newel auctions jake baer 2026” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Newel auctions jake baer”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “newel” (search terms considered: newel, auctions, jake, baer).

Even the shorter phrase “Newel auctions jake” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (newel, auctions, jake, baer) point to a business outside the SEC system or one known by another legal name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “newel” 1, “auctions” 11, “jake” 37, “baer” 58. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “newel”: NEWEL CORP (CIK 1911489); containing “auctions”: GREG MANNING AUCTIONS INC (CIK 895516), INSURANCE AUTO AUCTIONS CORP. (CIK 1336782), INSURANCE AUTO AUCTIONS INC /CA (CIK 880026); containing “jake”: DELHOMME JAKE (CIK 1587495), DUNGAN JAKE A (CIK 1302341), ERHARD JAKE F (CIK 1430678); containing “baer”: BAER ARTHUR H (CIK 1254150), BAER BARRY (CIK 1433313), BAER BEAT (CIK 1273005). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “newel” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Pasithea therapeutics corp. bullish and bearish analyst opinions

This section ties “Pasithea therapeutics corp. bullish and bearish analyst opinions” to Pasithea Therapeutics Corp. (ticker KTTA), SEC Central Index Key 1841330, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-16. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-30 by Pasithea Therapeutics Corp. (CIK 1841330) — source document:

We are a clinical-stage biotechnology company focused on the discovery, research and development of innovative treatments for RASopathies, MAPK pathway-driven tumors, and other diseases, including central nervous system (CNS) disorders. Our Therapeutic Pipeline We are advancing a pipeline of two therapeutic product candidates, with a focus on our lead product candidate, PAS-004, a next-generation macrocyclic (as defined below) Mitogen-Activated Protein Kinase (“MEK”) inhibitor, that we believe may address the limitations and liabilities associated with existing drugs with a similar mechanism of action. PAS-004 is a small molecule allosteric inhibitor of MEK 1 and 2 (“MEK 1/2”) for potential use in the treatment of a range of RASopathies, including neurofibromatosis type 1 (“NF1”), a number of MAPK pathway driven tumors, such as those driven by BRAFv600 mutations and BRAF fusion tumors, amyotrophic lateral sclerosis (“ALS”), among other indications including ETS2 driven diseases, such as inflammatory bowel disease (“IBD”), primary sclerosing cholangitis and ankylosing spondylitis.

Financial trend for Pasithea Therapeutics Corp. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2022-12-31 at $486,559; net income (loss) went from -$13.94 million (2022-12-31) to -$20.43 million (2025-12-31), a change of -46.6%; total assets went from $45.18 million (2022-12-31) to $60.24 million (2025-12-31), a change of +33.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1841330, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Pasithea Therapeutics Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Pasithea Therapeutics Corp. (CIK 1841330) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-30. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 41 8-K or 6-K reports in Pasithea Therapeutics Corp.’s recent EDGAR index, the 4 listed here run from 2026-05-04 to 2026-09-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1841330 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2021-01-29. Insider trades for Pasithea Therapeutics Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Patrick bui

What this search refers to. “Patrick bui” is a personal name; if the person is a securities professional, FINRA BrokerCheck and the SEC’s Investment Adviser Public Disclosure site are the official records, and individuals otherwise appear in EDGAR only as insiders on Forms 3, 4 and 5. Official source: brokercheck.finra.org.

No SEC filer could be matched to “Patrick bui” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Patrick bui”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “patrick” (search terms considered: patrick, bui).

EDGAR’s company index has 199+ entities whose registered name contains the word “patrick”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “patrick” 496, “bui” 14. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “patrick”: ABBOTT JOSEPH PATRICK JR. (CIK 1669907), ABER PATRICK JOHN (CIK 2104326), ABRAHAM PATRICK M (CIK 1232554); containing “bui”: BUI ANDY (CIK 1836866), BUI DINH N (CIK 1258291), BUI GIANG HUONG (CIK 1994547). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “patrick” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Phaos technology holdings (caym bullish and bearish analyst opinions

What this search refers to. The truncated “(caym” in this query indicates a Cayman Islands holding company; Cayman-incorporated groups normally list in Hong Kong or the U.S., and the Cayman General Registry records only basic incorporation details. Official source: www.hkexnews.hk.

No SEC filer could be matched to “Phaos technology holdings (caym bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Phaos technology holdings caym”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “phaos” (search terms considered: phaos, technology, caym).

A broader EDGAR full-text search for the shorter phrase “Phaos technology holdings” finds 165+ filing documents; among the top 100, the filers mentioning it most are Phaos Technology (Cayman) Holdings Ltd (POAS) (CIK 0002024258) (65); PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd (POAS) (CIK 0002024258) (31); Phaos Technology (Cayman) Holdings Ltd (CIK 0002024258) (4). Those are documents that name the term, not proof that any of these filers is the business in the search.

EDGAR’s company index has 1 entities whose registered name contains the word “phaos”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “phaos” 1, “technology” 485, “caym” 0. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “phaos” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Primo brands prmb latest news october 2026

This section ties “Primo brands prmb latest news october 2026” to Primo Brands Corp (ticker PRMB), SEC Central Index Key 2042694, an EDGAR registrant classified as “Beverages” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-02. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-27 by Primo Brands Corp (CIK 2042694) — source document:

When used in this report, the terms “the Company,” “our Company,” “ Primo Brands ,” “we,” “us,” or “our” refers to Primo Brands Corporation, together with its consolidated subsidiaries, for periods following the Transaction (as defined below) and to Triton Water Parent, Inc. and its consolidated subsidiaries (collectively, “BlueTriton”) and/or Primo Water Corporation and its consolidated subsidiaries (collectively, “Primo Water”) for periods prior to the Transaction. Primo Brands is a leading North American branded beverage company focused on healthy hydration, delivering responsibly sourced diversified offerings across products, formats, channels, price points and consumer occasions, distributed in every U.S. state and Canada. We were organized as a Delaware corporation in 2024, initially under the name Triton US HoldCo, Inc.

Financial trend for Primo Brands Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $4.44 billion (2022-12-31) to $6.66 billion (2025-12-31), a change of +50.1%; net income (loss) went from -$126.70 million (2022-12-31) to $60.10 million (2025-12-31), a change of +147.4%; total assets went from $5.15 billion (2023-12-31) to $10.60 billion (2025-12-31), a change of +105.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2042694, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Primo Brands Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Primo Brands Corp (CIK 2042694) filed 33 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-20, and its overall latest filing is a 4 dated 2026-10-02. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 33 8-K or 6-K reports in Primo Brands Corp’s recent EDGAR index, the 4 listed here run from 2026-07-16 to 2026-08-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2042694 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2024-11-08. Insider trades for Primo Brands Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Psyence biomedical ltd. bullish and bearish analyst opinions

This section ties “Psyence biomedical ltd. bullish and bearish analyst opinions” to PSYENCE BIOMEDICAL LTD. (ticker PBM, PBMWW), SEC Central Index Key 1985062, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in Ontario, Canada. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

Financial trend for PSYENCE BIOMEDICAL LTD. from annual reports, periods 2023-03-31 to 2025-03-31: net income (loss) went from -$3.21 million (2023-03-31) to $1.01 million (2025-03-31), a change of +131.6%; total assets was tagged only for 2023-03-31 at 1,590,255 CAD. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1985062, tags Assets, ProfitLoss; 3 periods shown, dashes mark figures PSYENCE BIOMEDICAL LTD. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on PSYENCE BIOMEDICAL LTD. (CIK 1985062) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-06-22. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 61 8-K or 6-K reports in PSYENCE BIOMEDICAL LTD.’s recent EDGAR index, the 4 listed here run from 2026-09-23 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 170 recent EDGAR filings, PSYENCE BIOMEDICAL LTD. most often filed 6-K (61), CORRESP (15), UPLOAD (13), EFFECT (10). A selection from 2026-08-26 to 2026-10-15:

The full record for CIK 1985062 is on the EDGAR company page; the latest 20-F there is dated 2026-06-22 and the oldest filing in the recent index dates from 2023-08-01. Insider trades for PSYENCE BIOMEDICAL LTD. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pt dci indonesia tbk bullish and bearish analyst opinions

Read from its name, “Pt dci indonesia tbk” is a Indonesia entity — “PT … Tbk” is the Indonesian form for a public limited company (Perseroan Terbatas Terbuka), the label used by companies listed on IDX. Its accounts and exchange notices are published through the Indonesia Stock Exchange (IDX) company-announcement system, supervised by OJK (www.idx.co.id); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Pt dci indonesia tbk bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Pt dci indonesia tbk” appears in 4 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “dci” (search terms considered: dci, indonesia).

A broader EDGAR full-text search for the shorter phrase “Pt dci indonesia” finds 4 filing documents; among the top 4, the filers mentioning it most are PT. DCI Indonesia Tbk/ADR (CIK 0002080855) (3); Citibank,N.A./ADR (CIK 0001472033) (3); FLEXSHARES TRUST (CIK 0001491978) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

The wording suggests a business based in Indonesia. Companies there file with Indonesia Stock Exchange (IDX) and the Financial Services Authority (OJK) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “dci” is therefore the Indonesia regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 4 most relevant full-text hits returned for “Pt dci indonesia tbk”, filings range from 2025-08-11 to 2026-08-12. The filers whose documents mention it most often are PT. DCI Indonesia Tbk/ADR (CIK 0002080855) (3 hits); Citibank,N.A./ADR (CIK 0001472033) (3 hits); FLEXSHARES TRUST (CIK 0001491978) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 21 entities whose registered name contains the word “dci”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “dci” 21, “indonesia” 36. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “dci” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET